tiprankstipranks

MorphoSys downgraded to Neutral from Buy at UBS

UBS downgraded MorphoSys to Neutral from Buy with a price target of EUR 68, up from EUR 47. The analyst cites the pending takeover by Novartis for the downgrade.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on MOR:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue